1. Home
  2. MCO vs BSX Comparison

MCO vs BSX Comparison

Compare MCO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moody's Corporation

MCO

Moody's Corporation

HOLD

Current Price

$448.19

Market Cap

80.7B

Sector

Finance

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$63.44

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCO
BSX
Founded
1900
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.7B
93.4B
IPO Year
1998
2010

Fundamental Metrics

Financial Performance
Metric
MCO
BSX
Price
$448.19
$63.44
Analyst Decision
Buy
Strong Buy
Analyst Count
17
21
Target Price
$542.06
$102.10
AVG Volume (30 Days)
932.5K
14.5M
Earning Date
04-22-2026
04-22-2026
Dividend Yield
0.92%
N/A
EPS Growth
21.40
55.20
EPS
13.67
1.94
Revenue
$4,204,100,000.00
$9,076,000,000.00
Revenue This Year
$8.51
$11.91
Revenue Next Year
$7.76
$10.26
P/E Ratio
$32.73
$33.29
Revenue Growth
N/A
12.49
52 Week Low
$402.28
$60.59
52 Week High
$546.88
$109.50

Technical Indicators

Market Signals
Indicator
MCO
BSX
Relative Strength Index (RSI) 53.51 38.72
Support Level $422.18 $60.59
Resistance Level $450.66 $76.77
Average True Range (ATR) 10.99 1.80
MACD 2.27 0.46
Stochastic Oscillator 78.37 29.82

Price Performance

Historical Comparison
MCO
BSX

About MCO Moody's Corporation

Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: